LUCIER GREGORY T 4

What Happened

• Gregory T. Lucier, a director of Maravai LifeSciences Holdings, Inc. (MRVI), was granted 46,293 restricted stock units (RSUs) on May 26, 2026. The award is reported at an implied value of $4.38 per share, for a total reported value of $202,763. This was an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: May 26, 2026. Form 4 filed May 28, 2026 (within the usual two-business-day reporting window).
• Price/value: $4.38 per share; total reported value $202,763.
• Shares owned after transaction: not disclosed in the filing.
• Footnote: These RSUs vest in full upon the earlier of one year from the grant date or the date of the 2027 Maravai annual meeting of stockholders.
• Transaction type: A = Award/Grant (not an immediate cash transaction).

Context

• RSUs are a form of equity compensation that convert to shares upon vesting; they do not represent immediate share purchases or sales and therefore are generally less direct as market-sentiment signals than open-market buys or sales. The vesting condition means the shares will only be issued if the vesting event occurs (time-based or meeting date).